4 Recruiting Studies Using Sparsentan
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Sparsentan
🔵 Active, Not Recruiting Phase4 💊 Investigational Drug / Biologic
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
📍 University of Alabama at Birmingham — Birmingham, Alabama
Proteinuria
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
📍 Travere Investigational Site — Birmingham, Alabama
Immunoglobulin A Nephropathy
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
📍 Cedars-Sinai Medical Center — Los Angeles, California
Focal Segmental Glomerulosclerosis
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
📍 Brigham and Women's Hospital — Boston, Massachusetts
Proteinuric Renal Disease
View Study & Checklist ➔